Scott D. Locke
Partner
Chair, Intellectual Property Department
Admissions:
New York
Connecticut
U.S. District Court, Southern District of New York
U.S. District Court, Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. Patent & Trademark Office
Education:
J.D., University of Pennsylvania School of Law, 1995
B.S. in Biology, Brown University, 1991,
magna cum laude
elected to Sigma Xi
Scott D. Locke is a Partner at Dorf & Nelson LLP and Chair of the Firm’s Intellectual Property Department. With over two decades of experience, Mr. Locke counsels and advises clients on both soft intellectual property and as a member of the patent bar, complex technologies. He works with solo inventors, start-up businesses and well-established companies in diverse industries for whom he provides strategies and tools for maximizing the return on investment in their ingenuity, creativity and goodwill.
Experience in Intellectual Property:
Mr. Locke handles all aspects in the life cycle of a client’s intellectual property, including: prosecution and registration, due diligence, clearance, licensing, and enforcement of patents, copyrights, trademarks and trade secrets. Dorf & Nelson’s clients operate in diverse industries, including fashion, cosmetics, luxury goods, biotechnology, industrial and organic chemical, e-commerce, information technology, pharmaceuticals, eco-friendly technologies, medical devices, artificial intelligence, CBD, and charitable institutions. Mr. Locke has handled a broad range of services for the Firm’s clients including:
-
-
- Drafting, filing and prosecuting hundreds of patent applications
- Registering of trademark and copyright rights
- Litigating patent, trademark and copyright cases
- Performing due diligence regarding intellectual property assets for potential acquisition
- Drafting and negotiating intellectual property licenses
- Counseling clients on data privacy and database protection
- Developing trade secrets protection policies
-
Experience in Life Sciences:
Mr. Locke has decades of experience advising, counseling and providing legal services to innovative clients in the Life Sciences industry including:
-
-
- Development of patent portfolio strategies for biotechnology companies, including those directed to siRNA and SNPs
- Conducting due diligence on patent portfolios that focus on molecular delivery systems
- Litigation of patents directed to pharmaceuticals, genotyping, nucleotide synthesis and medical devices
- Counseling medical device companies on protection and enforcement
- Prosecution of hundreds of patents directed to bioinformatics, RNAi, nucleotide sequences, oligonucleotide synthesis, pharmaceuticals and medical devices
-